![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1822546
¼¼°èÀÇ ¾È°ú¿ë ·¹ÀÌÀú ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, ¾÷°è µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)Ophthalmic Lasers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
Global Market Insights, Inc.°¡ ¹ßÇàÇÑ ÃֽŠº¸°í¼¿¡ µû¸£¸é ¼¼°èÀÇ ¾È°ú¿ë ·¹ÀÌÀú ½ÃÀåÀº 2024³â¿¡ 18¾ï ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, CAGR 5.9%·Î È®´ëµÇ¾î 2025³â 19¾ï ´Þ·¯¿¡¼ 2034³â±îÁö 31¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
ÀÌ ½ÃÀåÀº ½Ã·Â Àå¾ÖÀÇ ÀÌȯÀ² Áõ°¡, ³ëÈ, ¾È°ú ¼ö¼ú¿ë ·¹ÀÌÀú ½Ã½ºÅÛÀÇ ±â¼ú Áøº¸¿¡ ÀÇÇØ Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù.
¾È°ú¿ë ·¹ÀÌÀú´Â ³ì³»Àå, ´ç´¢º´¼º ¸Á¸·Áõ, ¿¬·É Ȳ¹Ýº¯¼º(AMD), ±¼Àý ÀÌ»ó°ú °°Àº ÁúȯÀÇ Ä¡·á¿¡ ÇʼöÀûÀÎ °ÍÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¾È°ú¿ë ·¹ÀÌÀú´Â Á¤È®Çϰí È¿°úÀûÀÎ ¼ö¼úÀ» Á¦°øÇÏ´Â ³·Àº ħ½À ÀåºñÀ̱⠶§¹®¿¡ ÇâÈÄ ¸î ³â µ¿¾È º¸±ÞÀÌ ÁøÇàµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ±Ý¾× | 18¾ï ´Þ·¯ |
¿¹Ãø ±Ý¾× | 31¾ï ´Þ·¯ |
CAGR | 5.9% |
1. ¾ÈÁúȯ Áõ°¡ : ¹é³»Àå, ´ç´¢º´¼º ¸Á¸·Áõ, ³ì³»Àå Áõ°¡·Î ·¹ÀÌÀú ±â¹Ý Ä¡·á ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
2. ±¼Àý ±³Á¤ ¼ö¼ú Áõ°¡ : ÀþÀº ¼¼´ëÀÇ ¶ó½Ä°ú SMILE ¼ö¼ú¿¡ ´ëÇÑ °ü½É Áõ°¡´Â ÆèÅäÃÊ ·¹ÀÌÀú¿Í ¿¢½Ã¸Ó ·¹ÀÌÀúÀÇ »ç¿ëÀ» ÃËÁøÇÕ´Ï´Ù.
3. ·¹ÀÌÀúÀÇ Á¤È®¼º°ú ¾ÈÀü¼º Çâ»ó : »õ·Î¿î ¾È°ú¿ë ·¹ÀÌÀú´Â º¸´Ù Áøº¸µÈ ÅëÁ¦, ´õ ÀûÀº ¿ ¼Õ»ó, ´õ ³ªÀº ¼ö¼ú ÈÄ °á°ú¸¦ Á¦°øÇϱâ À§ÇØ ¾È°ú ÀÇ»çµé »çÀÌ¿¡¼ ÁöÁö¸¦ ¸ðÀ¸°í ÀÖ½À´Ï´Ù.
4. Àα¸ °í·ÉÈ : ³ëÈ¿Í °ü·ÃµÈ ¾ÈÁúȯÀº ƯÈ÷ °í¼Òµæ ±¹°¡¿Í Áß¼Òµæ ±¹°¡¿¡¼ ¼¼°èÀûÀ¸·Î Áõ°¡ÇÏ´Â °æÇâÀÌ ÀÖ½À´Ï´Ù.
ÆèÅäÃÊ ·¹ÀÌÀú´Â Á¤È®¼º, ÃÖ¼Ò Ä§½À¼º, ±¼Àý ±³Á¤ ¼ö¼ú ¹× ¹é³»Àå ¼ö¼úÀÇ È¿°ú·Î 2024³â Á¦Ç° Ä«Å×°í¸®¸¦ ¼±µµÇß½À´Ï´Ù. ¶ó½Ä, SMILE ¹× °¢¸· Àý°³¿¡¼ÀÇ »ç¿ëÀº ½Ã·Â ±³Á¤¿¡ ´ëÇÑ È¯ÀÚÀÇ °ü½ÉÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àü ¼¼°èÀûÀ¸·Î ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
±¤ÀÀ°í¼úÀº ´ç´¢º´ ¸Á¸·ÁõÀ̳ª ¸Á¸· Á¤¸Æ Æó»öÁõÀÇ Ä¡·á¿¡ ´ëÇÑ ÀÌ¿ëÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ 2024³â¿¡µµ È£Á¶¸¦ À¯ÁöÇß½À´Ï´Ù. ÀÌ ±â¼úÀº ½Ã·ÂÀ» À§ÇùÇÏ´Â Áúº´À» Àå±âÀûÀ¸·Î ¾ÈÁ¤½Ãų ¼ö Àֱ⠶§¹®¿¡ ¸Á¸· Àü¹®ÀÇµé »çÀÌ¿¡¼ ¼±È£µË´Ï´Ù.
2024³â ½ÃÀåÀº ±¼ÀýÀÌ»ó ±³Á¤ÀÌ Áö¹èÀûÀ̾ú½À´Ï´Ù. ¾È°æ ¹× ÄÜÅÃÆ®·»Á ´ëüÇÏ´Â ¿µ±¸ÀûÀÎ ½Ã·Â ±³Á¤ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ƯÈ÷ µµ½Ã Áö¿ªÀÇ ·¹ÀÌÀú Áö¿ø ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù.
2024³â º´¿øÀº ÃÖÁ¾ ¿ëµµ ºÎ¹®À» µ¶Á¡Çß½À´Ï´Ù. º´¿ø ½Ã¼³Àº ÅëÇÕ ¾È°ú Ä¡·á ´ÜÀ§, À¯´ÉÇÑ ¿Ü°úÀÇ»ç, ÷´Ü ·¹ÀÌÀú Àåºñ¸¦ °®Ãß°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ º´¿øÀº Áø·á º¸»ó»óÀÇ ÀÌÁ¡À» °¡Áö°í ÀÖÀ¸¸ç ¼±ÅÃÀû ¾È°ú ¼ö¼ú°ú ÀÀ±Þ ¾È°ú ¼ö¼ú ¸ðµÎ¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» °®Ãß°í ÀÖ½À´Ï´Ù.
ºÏ¹Ì´Â 2024³â ¼¼°è ¾È°ú¿ë ·¹ÀÌÀú ½ÃÀå¿¡¼ °¡Àå Å« Áö¿ªÀÌ¿´À¸¸ç, ÀÌ´Â °í±Þ ¾È°ú ¼ö¼úÀÇ ±¤¹üÀ§ÇÑ »ç¿ë, ³ôÀº ±Ù½ÃÀ² ¹× ¹é³»Àå·ü, ±×¸®°í À¯¸íÇÑ ±â¾÷ÀÇ Á¸Àç·Î ÀÎÇÑ °ÍÀ̾ú½À´Ï´Ù. ¹Ì±¹Àº ±â¼ú µµÀÔ, »óȯ Á¦µµ, Á¤±³ÇÑ ·¹ÀÌÀú ±â¹Ý Ä¡·á¸¦ °®Ãá ¿Ü·¡ ¼ö¼ú ½Ã¼³ µîÀÇ Ãø¸é¿¡¼ ÃÖ÷´ÜÀ» À¯ÁöÇϰí ÀÖ½À´Ï´Ù.
ÁÖ¿ä ±â¾÷Àº °æÀï ¿ìÀ§¸¦ È®º¸Çϱâ À§ÇØ »õ·Î¿î R&D, Àü·«Àû Á¦ÈÞ, »õ·Î¿î Ãâ½Ã¸¦ ¸ð»öÇÏ°í ½ÇÇàÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, AlconÀº ÃÖ±Ù ¹é³»Àå°ú °¢¸· ¼ö¼úÀ» À§ÇÑ Â÷¼¼´ë ÆèÅäÃÊ ·¹ÀÌÀú·Î Æ÷Æ®Æú¸®¿À¸¦ ±¸ÃàÇß½À´Ï´Ù. ZEISS¿Í Johnson & JohnsonÀº ¼ö¼ú Á¤¹Ðµµ¸¦ Çâ»ó½ÃŰ´Â ÀΰøÁö´É À¯µµ ·¹ÀÌÀú Ç÷§Æû¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¹Ý´ë·Î Lumenis¿Í Glaukos´Â ¾È°ú Ŭ¸®´Ð ¹× º´¿ø°ú Á¦ÈÞÇÏ¿© ÆÇ¸Å ä³ÎÀ» ´õ Àß Áö¿øÇÏ´Â °ÍÀ» ¸ñÇ¥·ÎÇÕ´Ï´Ù. BAUSCH LOMB°ú NIDEKÀº ÇöÁö »ý»êÀ» ¸ð»öÇÏ°í ¾È°ú ÀÇ»çÀÇ ÈÆ·ÃÀ» ½Ç½ÃÇÔÀ¸·Î½á ½ÅÈï ½ÃÀå¿¡ ÃÊÁ¡À» ¸ÂÃá ¼ºÀå Àü·«À» ½Ç½ÃÇß½À´Ï´Ù. À̸¦ ÅëÇØ ¼¼°èÀûÀÎ µµ´Þ ¹üÀ§°¡ ´õ¿í ³Ð¾îÁú »Ó¸¸ ¾Æ´Ï¶ó ±â¼úÀÌ Áøº¸µÇ°í ȯÀÚÀÇ Ä¡·á ¼ºÀûÀÌ Çâ»óµË´Ï´Ù.
The global ophthalmic lasers market was valued at USD 1.8 billion in 2024 and is projected to grow from USD 1.9 billion in 2025 to USD 3.1 billion by 2034, at a CAGR of 5.9%, according to the latest report published by Global Market Insights, Inc. The market is experiencing significant growth with the growing incidence of vision disorders, the aging population, and technological advancements in laser systems for eye procedures.
Ophthalmic lasers have emerged as vital for the treatment of diseases like glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and refractive errors. Ophthalmic lasers are minimally invasive instruments that deliver precise and effective surgical treatments, and therefore are expected to show increased uptake over the next few years.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $1.8 Billion |
Forecast Value | $3.1 Billion |
CAGR | 5.9% |
1. Rising incidences of eye diseases: Increasing numbers of cataracts, diabetic retinopathy, and glaucoma are favoring the demand for laser-based treatments.
2. Rise in refractive surgeries: Increased interest in LASIK and SMILE surgeries among young generations is driving the usage of femtosecond and excimer lasers.
3. Improved precision and safety of lasers: New ophthalmic lasers provide enhanced control, less thermal damage, and better post-op results, thus gaining traction among ophthalmologists.
4. Aging population: Age-related eye conditions are on the rise worldwide, particularly in high-income and middle-income nations.
Femtosecond lasers led the product category in 2024 with their precision, minimal invasiveness, and efficacy in refractive and cataract surgeries. Their use in LASIK, SMILE, and corneal incisions is increasing rapidly due to the increasing patient interest in vision correction continues to rise worldwide.
The photocoagulation segment sustained a strong position in 2024, particularly because of the increasing usage in the treatment of diabetic retinopathy and retinal vein occlusions. The technology is preferred among retinal specialists as it offers long-term stabilization of vision-threatening disease.
Refractive error correction dominated the market in 2024. Growing demand for permanent vision correction solutions to glasses and contact lenses is propelling the demand for laser-assisted procedures, especially in urban areas.
Hospitals dominated the end-use segment in 2024. Hospital facilities have integrated eye care units, qualified surgeons, and high-tech laser equipment. They also offer reimbursement benefits and have the capacity to treat both elective and emergency ophthalmic surgeries.
North America was the biggest player in the global ophthalmic lasers market in 2024, driven by extensive use of advanced ophthalmic surgeries, high myopia and cataract rates, and the presence of prominent players. The U.S. remains at the forefront in terms of technology adoption, reimbursement schemes, and outpatient surgical facilities with sophisticated laser-based treatments.
Top players are exploring and executing new research and development, strategic partnerships, and new launches for competitive advantage. As an example, Alcon has recently built its portfolio with next-generation femtosecond lasers for cataract and corneal surgery. ZEISS and Johnson & Johnson are focused on artificial intelligence-guided laser platforms to improve surgical precision. Conversely, Lumenis and Glaukos aim to partner with eye clinics and hospitals to better support their distribution channels. BAUSCH + LOMB and NIDEK implement growth strategies focused on emerging markets by exploring local production and also training ophthalmologists. This will further global reach but also advance technology and improve patient care outcomes.